Yiting Dong

机构：Chinese Academy of Medical Sciences & Peking Union Medical College · ORCID：0000-0003-0850-031X

发表论文 25 篇 · 总被引 325 次 · h-index 11

代表论文

• MET-Targeted Therapies and Clinical Outcomes: A Systematic Literature Review (2022 · Molecular Diagnosis & Therapy · 被引 67)
• Butyrate protects against MRSA pneumonia via regulating gut-lung microbiota and alveolar macrophage M2 polarization (2023 · mBio · 被引 52)
• Blockade of STAT3/IL-4 overcomes EGFR T790M-cis-L792F-induced resistance to osimertinib via suppressing M2 macrophages polarization (2022 · EBioMedicine · 被引 34)
• A single-cell characterised signature integrating heterogeneity and microenvironment of lung adenocarcinoma for prognostic stratification (2024 · EBioMedicine · 被引 25)
• The Prognostic Value of Blood-Based Biomarkers in Patients With Testicular Diffuse Large B-Cell Lymphoma (2019 · Frontiers in Oncology · 被引 24)
• Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy (2024 · Nature Communications · 被引 21)